IMMUNOGENICITY AND SAFETY OF A TRIVALENT SUBUNIT IMMUNOADJUVANT INFLUENZA VACCINE IN CHILDREN WITH TYPE 1 DIABETES: RESULTS OF A PROSPECTIVE COMPARATIVE STUDY
Background: Children with type 1 diabetes (T1D) are at high risk for severe influenza. Objective. Our aim was to assess immunogenicity and safety of a trivalent subunit immunoadjuvant influenza vaccine in children with T1D. Methods. The prospective study carried out from September to November 2014 i...
Saved in:
Main Authors: | Аlla A. Tarasova (Author), Еlena V. Кolbasina (Author), Еlena F. Lukushkina (Author), Yury G. Kuzmichev (Author), Mikhail P. Kostinov (Author) |
---|---|
Format: | Book |
Published: |
"Paediatrician" Publishers LLC,
2016-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prospective randomized open-label comparative study of immunogenicity after subunit and polymeric subunit influenza vaccines administration among mothers and infants
by: Mikhail Petrovich Kostinov, et al.
Published: (2018) -
Immunogenicity and safety of a trivalent inactivated influenza vaccine
by: Eddy Fadlyana, et al.
Published: (2011) -
Immunogenicity of trivalent seasonal influenza vaccine in patients with chronic obstructive pulmonary disease
by: Yan Li, et al.
Published: (2021) -
Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China
by: Zhaojun Mo, et al.
Published: (2017) -
Immunogenicity of trivalent influenza vaccine in patients with lung cancer undergoing anticancer chemotherapy
by: Kei Nakashima, et al.
Published: (2017)